BAVIS_1170X120_10-19-20

February 15, 2021

‘Partial fill’ concept endorsed by NACDS

‘Partial fill’ concept endorsed by NACDS

ARLINGTON, Va. — The Drug Enforcement Administration’s (DEA’s) rulemaking that implements a 2016 law allowing for the partial filling of Schedule II controlled substances is a necessary step to help address the opioid abuse epidemic, yet changes are recommended to ensure success, according to the National Association of Chain Drug Stores. NACDS submitted comments this

Liebmann sees road ahead for retailing ‘totally open’

Liebmann sees road ahead for retailing ‘totally open’

ARLINGTON, Va. — In a recent webinar sponsored by the National Association of Chain Drug Stores, Wendy Liebmann, chief executive officer and chief shopper at WSL Strategic Retail, discussed how shoppers have been, and are being, transformed by the pandemic and offered insights on how retailers are responding and need to respond to meet the

A long, but fruitful pharmacy journey

A long, but fruitful pharmacy  journey

GLENCOE, Ill. — This is a story about Edwin Levin, an 82-year-old native of Chicago’s northern suburbs. Levin, a registered pharmacist, has spent much of his life behind or in front of various prescription counters, dispensing prescriptions, offering advice and generally doing what the most accomplished people in his profession routinely do: advise and counsel

Brewer’s appointment lifts WBA’s expectations

Brewer’s appointment lifts WBA’s expectations

DEERFIELD, Ill. — Stefano Pessina is bullish about the future of Walgreens Boots Alliance in the wake of Rosalind Brewer’s appointment to succeed him as the company’s chief executive officer. A former CEO of Walmart’s Sam’s Club division and currently chief operating officer and group president at Starbucks Corp., Brewer will join WBA on March

AmerisourceBergen becoming strategic partner

AmerisourceBergen becoming strategic partner

CONSHOHOCKEN, Pa. — Two decades ago AmeriSource Health merged with Bergen Brunswig to form AmerisourceBergen, one of the nation’s premier pharmaceutical distributors. Today the company, now a $185 billion global diversified health care services provider, is working to forge closer ties with its biggest customers in a bid to improve patient care and drive business.